PRIORITISE
TITRASKURAX
Now, more than ever, within the current pandemic, it is easy to forget that there are also other serious infectious respiratory diseases that we need to help prevent.1-8
Issa, aktar minn qatt qabel, fi ħdan din il-pandemija, huwa faċli li ninsew li hemm mard respiratorju infettiv ieħor serju li għandna bżonn nipprevjenu.1-8
Pneumonia is a lung infection that can be serious and sometimes fatal.9
Il-pulmonite’ hija infezzjoni tal-pulmun li tista’ tkun serja u saħansitra tista’ toqtol.9
Getting infected with the flu can increase your risk of contracting pneumococcal pneumonia as well.10
Jekk taqbdek l-influwenza tkun qiegħed iżżid ir-riskju li taqbdek ukoll il-pulmonite pnewmokokkali.10
According to US data, compared to healthy adults 65 years and older, adults 65 years and older with chronic common conditions are at increased risk for pneumococcal pneumonia.11
Skond dejta Amerikana, kumparat m’adulti f’saħħithom minn 65 sena l-fuq, adulti minn 65 sena l-fuq b’mard kroniku huma f’riskju akbar li taqbadhom pulmonite pnewmokokkali.11
Getting vaccinated against the flu and pneumococcal pneumonia may help reduce your risk of contracting these respiratory diseases.6, 8, 12
Li titlaqqam kontra l-influwenza u l-pulmonite pnewmokokkali jista’ jgħin biex tnaqqas ir-riskju li jaqbdek dan il-mard respiratorju.6, 8, 12
SPEAK TO YOUR DOCTOR OR PHARMACIST
GET VACCINATED AGAINST PNEUMOCOCCAL PNEUMONIA
PP-PNA-MAL-0015-OCT21
Pfizer is one of the world’s leading biopharmaceutical companies. This microsite is supported by Pfizer to educate and increase disease awareness.
Vivian is a local distributor for Pfizer’s products.
REFERENCES
1. Pijls BG, Jolani S, Atherley A, et al. Demographic risk factors for COVID-19 infection, severity, ICU admission and death: a meta-analysis of 59 studies. BMJ Open. 2021;11:e044640. doi:10.1136/ bmjopen-2020-044640.
2. Gao Y-D, Ding M, Dong X, et al. Risk factors for severe and critically ill COVID-19 patients: a review. Allergy. 2021;76:428-455.
3. Gold, MS, Sehayek D, Gabrielli S, et al. COVID-19 and comorbidities: a systematic review and meta-analysis. Postgrad Med. 2020;132(8): 749-755.
4. GBD 2015 LRI Collaborators. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory tract infections in 195 countries: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Infect Dis. 2017. doi:10.1016/S1473-3099(17)30481-4.
5. Meyer KC. Lung infections and aging. Ageing Res. Rev. 2004;55–67.
6. Centers for Disease Control and Prevention (CDC). Key Facts About Influenza (Flu). https://www.cdc.gov/flu/about/keyfacts.htm Page last reviewed August 26, 2021. Accessed September 2021.
7. Centers for Disease Control and Prevention (CDC). Pneumococcal Disease. Risk Factors and Transmission. https://www.cdc.gov/pneumococcal/about/risk-transmission.html Page last reviewed September 1, 2020. Accessed September 2021.
8. Centers for Disease Control and Prevention (CDC). Pneumonia Can Be Prevented—Vaccines Can Help. https://www.cdc.gov/pneumonia/prevention.html Page last reviewed October 22, 2020. Accessed September 2021.
9. Mayo Clinic. Pneumonia. Available at https://www.mayoclinic.org/diseases-conditions/pneumonia/symptoms-causes/syc-20354204. Last accessed September 2021.
10. Weinberger DM, et al. Impact of the 2009 influenza pandemic on pneumococcal pneumonia hospitalizations in the United States. J Infect Dis. 2012;205(3):458-465.
11. Shea KM, Edelsberg J, Weycker D, et al. Rates of pneumococcal disease in adults with chronic medical conditions. Open Forum Infect Dis. 2014;1(1):ofu024. doi: 10.1093/ofid/ofu024.
12. McLaughlin JM, McGinnis JJ, Tan L, Mercatante A, Fortuna J. Estimated Human and Economic Burden of Four Major Adult Vaccine-Preventable Diseases in the United States, 2013. J Prim Prev. 2015 Aug;36(4):259-73. doi: 10.1007/s10935-015-0394-3.
